{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-24-004480","form_type":"8-K","ticker":"SLSN","cik":"0000883107","company_name":"SOLESENCE, INC.","filed_at":"2024-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.148181+00:00","generated_at":"2026-05-31T12:49:36.026128+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Nanophase reports record Q2 revenue $13M (+10% YoY) and net income $856K (+157%)","bullets":["Q2 revenue $13M vs $11.9M in Q2 2023 (+10%); Solésence revenue $11.2M (+44% YoY).","First half 2024 net income $1.7M vs loss $0.8M in H1 2023; gross profit $7.3M (+26%).","Second half revenue expected to exceed first half by more than 20% per management.","Won third consecutive Cosmopack North America Formulation Award for Lip Oil SPF 40+.","Q2 net income $856K vs $333K in prior year period, a 157% increase."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-24-004480","json":"https://secwatch.observer/filing/0001171843-24-004480.json","markdown":"https://secwatch.observer/filing/0001171843-24-004480.md","text":"https://secwatch.observer/filing/0001171843-24-004480.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883107/000117184324004480/0001171843-24-004480-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883107/000117184324004480/f8k_080624.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T12:49:36.026128+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}